Previous close | 182.17 |
Open | 183.45 |
Bid | 185.09 x 800 |
Ask | 185.00 x 900 |
Day's range | 182.17 - 186.85 |
52-week range | 135.85 - 186.85 |
Volume | |
Avg. volume | 5,461,266 |
Market cap | 326.968B |
Beta (5Y monthly) | 0.62 |
PE ratio (TTM) | 62.13 |
EPS (TTM) | 2.98 |
Earnings date | 25 Oct 2024 - 29 Oct 2024 |
Forward dividend & yield | 6.20 (3.35%) |
Ex-dividend date | 15 Jul 2024 |
1y target est | 187.64 |
AbbVie ( NYSE:ABBV ) Second Quarter 2024 Results Key Financial Results Revenue: US$14.5b (up 4.3% from 2Q 2023). Net...
AstraZeneca (AZN), Sanofi (SNY) and AbbVie (ABBV) announce second-quarter results. Merck (MRK) and Pfizer's (PFE) phase III studies achieve primary goals.